Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
Domènech E, Esteve-Comas M, Gomollón F, Hinojosa J, Obrador A, Panés J, Gassull MA; Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Domènech E, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2002 Mar;25(3):162-9. doi: 10.1016/s0210-5705(02)79012-2. Gastroenterol Hepatol. 2002. PMID: 11864540 Spanish. No abstract available.
[Budesonide and inflammatory bowel disease].
Gomollón F, Hinojosa J, Nos P. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 1999 Dec;22(10):525-32. Gastroenterol Hepatol. 1999. PMID: 10650668 Review. Spanish. No abstract available.
Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA; Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Domènech E, et al. Among authors: hinojosa j. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1347-52. doi: 10.1111/j.1365-2036.2004.02288.x. Aliment Pharmacol Ther. 2004. PMID: 15606397 Free article.
[Consensus document on the use of granulocytapheresis in patients with inflammatory bowel disease].
Cabriada JL, Doménech E, Gomollón F, González-Carro P, González-Lara V, Hinojosa J, Jiménez-López CE, Nos P, Obrador A, Panès J, Saro C, Varea V, Lafuente R, Guilera M. Cabriada JL, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2006 Feb;29(2):85-92. doi: 10.1157/13083905. Gastroenterol Hepatol. 2006. PMID: 16448611 Spanish. No abstract available.
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial.
Hinojosa J, Gomollón F, García S, Bastida G, Cabriada JL, Saro C, Ceballos D, Peñate M, Gassull MA; Spanish Scientific Group on Crohn's Disease and Ulcerative Colitis. Hinojosa J, et al. Aliment Pharmacol Ther. 2007 Feb 15;25(4):409-18. doi: 10.1111/j.1365-2036.2006.03232.x. Aliment Pharmacol Ther. 2007. PMID: 17269996 Free article. Clinical Trial.
[Steroids: friends or foes?].
Gomollón F, Hinojosa J. Gomollón F, et al. Among authors: hinojosa j. Gastroenterol Hepatol. 2008 Sep;31 Suppl 3:1-2. Gastroenterol Hepatol. 2008. PMID: 19087856 Spanish. No abstract available.
437 results